CHINA PHARMA HLDGS INC's ticker is CPHI and the CUSIP is 16941T104. A total of 7 filers reported holding CHINA PHARMA HLDGS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $2,196 | -26.8% | 22,900 | -0.4% | 0.00% | – |
Q3 2022 | $3,000 | -40.0% | 23,000 | -2.5% | 0.00% | – |
Q2 2022 | $5,000 | -54.5% | 23,600 | -15.7% | 0.00% | – |
Q1 2022 | $11,000 | -26.7% | 28,000 | -11.4% | 0.00% | – |
Q4 2021 | $15,000 | +87.5% | 31,600 | +122.5% | 0.00% | – |
Q3 2021 | $8,000 | – | 14,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
POPE ASSET MANAGEMENT, LLC | 2,101,626 | $546,000 | 0.40% |
GLENHILL ADVISORS LLC | 200,000 | $52,000 | 0.00% |
GOLDMAN SACHS GROUP INC | 10,110 | $3,000 | 0.00% |
Citadel Advisors | 16,114 | $4,000 | 0.00% |
Renaissance Technologies | 133,600 | $35,000 | 0.00% |
PARSONS CAPITAL MANAGEMENT INC/RI | 10,000 | $3,000 | 0.00% |
Virtu KCG Holdings LLC | 27,255 | $7,000 | 0.00% |
UBS Group AG | 50 | $0 | 0.00% |